Fierce Pharma

JANUARY 11, 2024

Dermavant’s topical cream Vtama, already on the market for plaque psoriasis as a steroid-free treatment, is compiling impressive data in pursuit of an FDA approval in atopic dermatitis (AD). | Dermavant’s topical cream Vtama, already on the market for plaque psoriasis as a steroid-free treatment, is compiling impressive data in pursuit of an FDA approval in atopic dermatitis (AD).

FDA 312

FDA Marketing 312

PharmaVoice

JANUARY 11, 2024

As advanced therapies and patient perspectives strengthen their foothold in R&D, pharma is poised to deliver impactful treatments in record time.

Pharma 131

Pharma Patients 131

Fierce Pharma

JANUARY 11, 2024

With sales declining for aging MS drug Fampyra, Biogen has exercised an option to return licensing rights outside of the U.S. to Acorda Therapeutics.

Sales 299

Sales 299

MedCity News

JANUARY 11, 2024

At CES 2024, menopause startup Amira launched The Terra System, a wearable cooling device that supports women battling hot flashes and helps them sleep through the night.

126

126

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JANUARY 11, 2024

Pfizer is still hungry for ADC opportunities, including in the Far East. | Pfizer mused on ADC opportunities in China, while Takeda's R&D head revealed details behind the company's competitive TYK2 deal with Nimbus at this year's J.P. Morgan Healthcare Conference. Astellas received a manufacturing-related rejection for its gastric cancer candidate.

Competition 130

Competition Pharma Manufacturing Healthcare 130

MedCity News

JANUARY 11, 2024

Generic competition has eroded sales of multiple sclerosis drug Ampyra, marketed as Fampyra outside the U.S. Biogen told Acorda Therapeutics that it’s terminating its ex-U.S. rights to Fampyra in order to focus on other priorities, which include expanding beyond MS.

Competition 124

Competition Sales Marketing Biopharma 124

MedCity News

JANUARY 11, 2024

This year’s J.P. Morgan Healthcare Conference brought a bevy of news announcements — from acquisitions to partnerships to new products and more. This list compiles short summaries for seven of the event’s most notable announcements.

Healthcare 123

Healthcare Healthcare Biopharma 123

PharmaTimes

JANUARY 11, 2024

The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser

111

111

MedCity News

JANUARY 11, 2024

This year, ViVE will celebrate nurses throughout the event’s programming, highlighting how their role has evolved, the challenges they face and how they are spurring innovation in different models of care. The event is powered by HLTH and the College of Healthcare Information Management Executives (CHIME).

Healthcare 120

Healthcare Healthcare Management 120

European Pharmaceutical Review

JANUARY 11, 2024

Quotient Sciences leverage more than 30 years of drug development expertise to support small molecule and synthetic peptide drug programmes, in both simple drug programmes as well as complex cases where specialised formulation expertise and technologies are required. All drug development programmes are challenging, with numerous stages that an active, lead molecule or new chemical entity (NCE) must transition through to gain regulatory approval and demonstrate its benefits to patients Find out m

Leads 111

Leads Pharmaceutical Patients 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JANUARY 11, 2024

The hospital sector’s financial performance in November showed signs of continued stabilization and growth, according to Kaufman Hall’s latest monthly report. Hospitals should “take advantage of the relative stability and re-embrace strategic growth if they hope to see continued success in 2024,” stated Erik Swanson, one of the report’s authors.

Marketing 119

Marketing 119

pharmaphorum

JANUARY 11, 2024

CHMP has called in expert advisors to assist in the review of Eisai and Biogen’s Alzheimer's therapy Leqembi

111

111

MedCity News

JANUARY 11, 2024

The FDA has found no clear relationship between GLP-1 drugs, such as Ozempic and Mounjaro, and reports of suicidal thoughts or actions. But the agency added that it can’t definitively rule out the risk, and its review is ongoing.

FDA 118

FDA Safety Biopharma Pharma 118

pharmaphorum

JANUARY 11, 2024

FDA has authorised imports from France of a life-saving antibiotic for syphilis that is in short supply in the domestic market

FDA 110

FDA Marketing 110

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

PharmaTimes

JANUARY 11, 2024

In 2022, around 8% of patients survived 30 days after a cardiac arrest

Patients 107

Patients 107

pharmaphorum

JANUARY 11, 2024

NICE has extended the NHS availability of Pfizer’s COVID-19 drug Paxlovid as millions of doses approach their expiry date

105

105

European Pharmaceutical Review

JANUARY 11, 2024

chronic neuropathic pain is at present, mainly managed with antidepressants… antiepileptic drugs… as well as opioids” Neuropathic pain affects over 400 million people worldwide, according to Hoba Therapeutics. In Europe, the prevalence of chronic neuropathic pain is estimated to be six–eight percent 1 of the general population. Drug development for pain management is “incredibly complex… mainly because the trials are so challenging to conduct”, the company highlight

Medicine 102

Medicine Pharmacology Management Side effects 102

pharmaphorum

JANUARY 11, 2024

Stada and Alvotech get EU approval for first biosimilar of Johnson & Johnson's Stelara in psoriasis, psoriatic arthritis and Crohn's disease indications

105

105

Advertisement

European Pharmaceutical Review

JANUARY 11, 2024

Researchers at the Institute for Molecular Science in Japan have successfully observed vibrational spectra of single proteins using infrared nanospectroscopy. The observations made consisted of ~500 amino acid residues, using advanced measurement techniques based on near-field optical microscopy. Comparatively, this method is a challenge with conventional infrared spectroscopy.

Leads 98

Leads Pharmaceutical 98

Pharmacy Times

JANUARY 11, 2024

Variations and conditions included in existing state bills, however, limit the effectiveness of this approach.

61

61

European Pharmaceutical Review

JANUARY 11, 2024

ACC pioneered LAL testing methodology and was the first FDA-licensed company to manufacture LAL reagents. Throughout the years it has grown to be an internationally recognised leader in endotoxin detection. In 2021, they introduced the first commercially available sustainable bacterial endotoxin testing (BET) recombinant Cascade Reagent (rCR), PyroSmart NextGen®.

Manufacturing 95

Manufacturing FDA Pharmaceutical 95

PharmaTech

JANUARY 11, 2024

Pluri has launched PluriCDMO, a new contract development and manufacturing organization business that will offer cell therapy manufacturing services.

Manufacturing 59

Manufacturing 59

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

JANUARY 11, 2024

Though not approved in the US, Laboratoires Delbert’s extencilline will be the available alternative to Pfizer’s Bicillin L-A.

FDA 59

FDA 59

Clarivate

JANUARY 11, 2024

At Clarivate TM , our mission is to advance the success of people and organizations through transformative intelligence and trusted partnership. We are proud to spotlight our women IP experts, whose professionalism and talent make up the core fabric of our endeavour. Continuing this blog series, we present Katie Clapham, Senior Director of IP Partnerships at Clarivate.

Specialization 59

Specialization 59

Pharmaceutical Technology

JANUARY 11, 2024

Expanded patient groups at risk of progression to severe Covid-19 will be eligible for Pfizer’s antiviral pill.

Patients 59

Patients 59

Pharmacy Times

JANUARY 11, 2024

These patients may have a similar genetic susceptibility for type 2 diabetes, although they have an individual risk for GDM independent of the risk of type 2 diabetes.

Patients 58

Patients 58

Advertisement

Distribution

Pharmaceutical Technology

JANUARY 11, 2024

BridgeBio submitted the NDA with US FDA for the TTR stabiliser in December 2023 and plans to engage with other regulatory bodies this year.

FDA 59

FDA 59

Pharmacy Times

JANUARY 11, 2024

To have skin-deep resilience is to overcome adversity to achieve success, be it psychological or academic.

55

55

PharmaTech

JANUARY 11, 2024

Webinar Date/Time: Wed, Feb 7, 2024 10:30 AM CET (4:30 AM EST)

Pharmaceutical products 52

Pharmaceutical products Pharmaceutical 52

Pharmacy Times

JANUARY 11, 2024

The data also suggest that further studies investigating a plausible causal relationship between pneumonia and type 1 diabetes are needed.

55

55

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales